Shenker, Andrew

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factorXa inhibitor, in healthy subjects

Frost, C., Nepal, S., Wang, J., Schuster, A., Byon, W., Boyd, R. A., Yu, Z., Shenker, A., Barrett, Y. C., Mosqueda‐Garcia, R., et al. (2013) · British Journal of Clinical Pharmacology

Atrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis Mechanisms

Cited by 286

G protein-coupled receptor structure and function: the impact of disease-causing mutations

Shenker, A. (1995) · Baillière's Clinical Endocrinology and Metabolism

Receptor Mechanisms and SignalingProtein Kinase Regulation and GTPase Signaling

Cited by 81

Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects

Byon, W., Nepal, S., Schuster, A. E., Shenker, A., & Frost, C. E. (2018) · The Journal of Clinical Pharmacology

Drug Solubulity and Delivery SystemsPharmacogenetics and Drug Metabolism

Cited by 52